Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michael Deaney"'
Autor:
Michael Deaney, Dale Terasaki
Publikováno v:
Journal of the American Pharmacists Association.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5098ecc1d8640a1eb6abbdec32b1ffc5
https://doi.org/10.1016/j.japh.2023.05.010
https://doi.org/10.1016/j.japh.2023.05.010
Autor:
Y Vivian Tsai, Morgan Pizzuti, Michael Deaney, P Brandon Bookstaver, Divya Ahuja, Caroline Derrick
Publikováno v:
Open Forum Infectious Diseases. 9
Background Cabotegravir/rilpivirine (CAB/RPV) long-acting (LA) injectable was recently approved as a switch therapy for people living with HIV (PLWHIV) who are virologically suppressed on oral combination antiretroviral therapy (cART). Data demonstra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e6d5e82533b02f6cf64f3f81cae5f5f
https://doi.org/10.1093/ofid/ofac492.1691
https://doi.org/10.1093/ofid/ofac492.1691
Autor:
Kennedy J Freeman, Madeline Harper, Malashia Drummond, Jeannette Bouchard, Alexandria Waddell, Caroline Derrick, Sharon Weissman, Michael Deaney, Helmut Albrecht, Nancy M Joyner, Hannah G Brown
Publikováno v:
Open Forum Infectious Diseases
Background Convalescent plasma (CP) may be obtained from patients who have recovered from the novel coronavirus disease, COVID-19, caused by the virus SARS-CoV-2. Although not FDA approved, preliminary data suggests patients who receive convalescent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d819bab9a4509ad6ece5aa5b044fe04
https://doi.org/10.1093/ofid/ofaa439.1312
https://doi.org/10.1093/ofid/ofaa439.1312